Irish Medicines Board Act, 1995
|
Interpretation. |
1.—(1) In this Act unless the context otherwise requires— | |
“the Board” means the Irish Medicines Board; | ||
“the Chief Executive” means the chief executive officer of the Board; | ||
“a committee” means a committee appointed under section 9 ; | ||
“cosmetic product” has the meaning assigned to it by Council Directive No. 93/35/EEC of 14 June 1993(1) ; | ||
“the establishment day” means the day appointed by the Minister under section 2 ; | ||
“the former Board” means the National Drugs Advisory Board established under the Health (Corporate Bodies) Act, 1961 ; | ||
“functions” includes powers and duties and references to the performance of functions includes as respects powers and duties, references to the exercise of the powers and the carrying out of the duties; | ||
“medicinal product” has the meaning assigned to it by Council Directive No. 65/65/EEC of 26 January 1965(2) ; | ||
“the Minister” means the Minister for Health; | ||
“recognised trade unions and staff associations” means the trade unions and staff associations recognised by the Board for the purpose of negotiations which are concerned with the remuneration, conditions of employment or working conditions of officers of the Board and employees of the Board. | ||
(2) In this Act— | ||
(a) a reference to any enactment shall, unless the context otherwise requires, be construed as a reference to that enactment as amended or extended by or under any subsequent enactment including this Act, | ||
(b) a reference to a section is a reference to a section of this Act unless it is indicated that reference to some other enactment is intended, | ||
(c) a reference to a subsection, paragraph or subparagraph is a reference to the subsection, paragraph or subparagraph of the provision in which the reference occurs unless it is indicated that reference to some other provision is intended. | ||